Skip to content

Pfizer PFE Compensation and benefits

Compensation and benefits at other companies

Eli Lilly logo
Eli LillyLLY
Johnson & Johnson logo
Johnson & JohnsonJNJ
Incyte logo
IncyteINCY
Moderna logo
ModernaMRNA
Viatris logo
ViatrisVTRS
Roivant Sciences logo
Roivant SciencesROIV

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+5.0%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$143.68B+11.1%
Enterprise value$206.35B+9.2%
P/E11.9×
P/S2.3×+0.2×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Reported directly by Pfizer in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The official record: Pfizer’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's compensation and benefits?
Pfizer (PFE) reported compensation and benefits of $2.72B in Q1 2026.
How has Pfizer's compensation and benefits changed year-over-year?
Pfizer's compensation and benefits increased by 4.1% year-over-year, from $2.61B to $2.72B.
What is the long-term trend for Pfizer's compensation and benefits?
Over 5 years (2020 to 2025), Pfizer's compensation and benefits has grown at a 3.4% compound annual growth rate (CAGR), from $3.05B to $3.61B.